Most of you reading this understand that testosterone, estrogen, and thyroid decline with age. Restoring them brings back vitality, improves metabolism, and gives people a second life.
But does the same logic apply to peptides that already exist in the human body? If we replace hormones when they decline, should peptide replacement therapy become common practice? Peptides are not foreign substances. They are naturally occurring compounds in the human body. When we lose them, we lose the body’s internal language of healing. Let’s make the case for mainstreaming peptide therapy.
Macro vs. Micro
Our body depends on peptides for nearly everything. They tell cells when to divide, repair, and adapt. Every signal that keeps you alive runs through them. Most of the therapeutic peptides people use today already exist within the human body. Molecules like Thymosin Alpha-1, GHK, Humanin, MOTS-c, and BPC are all endogenously derived. They come from your thymus, your plasma,your mitochondria, or your gut. They are part of us! In our younger years, these peptides are abundant. By the time most people reach middle age, their levels have fallen by half or more. And by the time we reach old age, many are nearly gone. When that network of signaling declines, you lose the programs that tell your body how to regenerate.
